Page last updated: 2024-10-20

pyrazole and Atrial Fibrillation

pyrazole has been researched along with Atrial Fibrillation in 1 studies

1H-pyrazole : The 1H-tautomer of pyrazole.

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research Excerpts

ExcerptRelevanceReference
" This compound also showed good bioavailability in rats and robust pharmacodynamic effects in a rabbit model."1.35Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists. ( Atwal, K; Bhandaru, R; Conder, M; Finlay, HJ; Huang, CS; Huynh, T; Jenkins-West, T; Kover, A; Levesque, P; Li, D; Lloyd, J; Prol, J; Sun, H; Vaccaro, W; Yan, L, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lloyd, J1
Finlay, HJ1
Atwal, K1
Kover, A1
Prol, J1
Yan, L1
Bhandaru, R1
Vaccaro, W1
Huynh, T1
Huang, CS1
Conder, M1
Jenkins-West, T1
Sun, H1
Li, D1
Levesque, P1

Other Studies

1 other study available for pyrazole and Atrial Fibrillation

ArticleYear
Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists.
    Bioorganic & medicinal chemistry letters, 2009, Sep-15, Volume: 19, Issue:18

    Topics: Animals; Atrial Fibrillation; Cell Line; Humans; Kv1.5 Potassium Channel; Mice; Potassium Channel Bl

2009